Amgen's Revenue
- Amgen's annual revenue was $33.42 B in fiscal year 2024. The annual revenue increased $5.23 B from $28.19 B (in 2023) to $33.42 B (in 2024), representing a 18.57% year-over-year growth.
- Amgen's quarterly revenue was $9.09 B in the quarter ending Dec 2024. The quarterly revenue increased $890.00 M from $8.20 B (in Q4: Sept 2023) to $9.09 B (in Q4: Sept 2024), representing a 10.86% year-over-year growth.
- The highest annual revenue for Amgen was $33.42 B in fiscal year 2024.
- The lowest annual revenue was $21.66 B in fiscal year 2015.
- The average revenue was $25.40 B.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015 - 2024):
Learn more about Amgen's Revenue by Segment and Revenue by Region.
Check out competitors to Amgen in a side-by-side comparison.
Explore additional financial metrics for Amgen.
Definition of Revenue :
| 2014 | 20063000000.00 |
|---|---|
| 2015 | 21662000000.00 |
| 2016 | 22991000000.00 |
| 2017 | 22849000000.00 |
| 2018 | 23747000000.00 |
| 2019 | 23362000000.00 |
| 2020 | 25424000000.00 |
| 2021 | 25979000000.00 |
| 2022 | 26323000000.00 |
| 2023 | 28190000000.00 |
| 2024 | 33424000000.00 |
| Mar 2015 | 5033000000.00 |
|---|---|
| Jun 2015 | 5370000000.00 |
| Sep 2015 | 5723000000.00 |
| Dec 2015 | 5536000000.00 |
| Mar 2016 | 5527000000.00 |
| Jun 2016 | 5688000000.00 |
| Sep 2016 | 5811000000.00 |
| Dec 2016 | 5965000000.00 |
| Mar 2017 | 5464000000.00 |
| Jun 2017 | 5810000000.00 |
| Sep 2017 | 5773000000.00 |
| Dec 2017 | 5802000000.00 |
| Mar 2018 | 5554000000.00 |
| Jun 2018 | 6059000000.00 |
| Sep 2018 | 5904000000.00 |
| Dec 2018 | 6230000000.00 |
| Mar 2019 | 5557000000.00 |
| Jun 2019 | 5871000000.00 |
| Sep 2019 | 5737000000.00 |
| Dec 2019 | 6197000000.00 |
| Mar 2020 | 6161000000.00 |
| Jun 2020 | 6206000000.00 |
| Sep 2020 | 6423000000.00 |
| Dec 2020 | 6634000000.00 |
| Mar 2021 | 5901000000.00 |
| Jun 2021 | 6526000000.00 |
| Sep 2021 | 6706000000.00 |
| Dec 2021 | 6846000000.00 |
| Mar 2022 | 6238000000.00 |
| Jun 2022 | 6594000000.00 |
| Sep 2022 | 6652000000.00 |
| Dec 2022 | 6839000000.00 |
| Mar 2023 | 6105000000.00 |
| Jun 2023 | 6986000000.00 |
| Sep 2023 | 6903000000.00 |
| Dec 2023 | 8196000000.00 |
| Mar 2024 | 7447000000.00 |
| Jun 2024 | 8388000000.00 |
| Sep 2024 | 8503000000.00 |
| Dec 2024 | 9086000000.00 |
2024
Amgen's annual revenue was $33.42 B in fiscal year 2024.
Amgen's quarterly revenue was $7.45 B(Q1: Mar 2024), $8.39 B(Q2: Jun 2024), $8.50 B(Q3: Sep 2024), $9.09 B(Q4: Dec 2024) in fiscal year 2024.
2023
Amgen's annual revenue was $28.19 B in fiscal year 2024.
Amgen's quarterly revenue was $6.11 B(Q1: Mar 2023), $6.99 B(Q2: Jun 2023), $6.90 B(Q3: Sep 2023), $8.20 B(Q4: Dec 2023) in fiscal year 2023.
2022
Amgen's annual revenue was $26.32 B in fiscal year 2024.
Amgen's quarterly revenue was $6.24 B(Q1: Mar 2022), $6.59 B(Q2: Jun 2022), $6.65 B(Q3: Sep 2022), $6.84 B(Q4: Dec 2022) in fiscal year 2022.
2021
Amgen's annual revenue was $25.98 B in fiscal year 2024.
Amgen's quarterly revenue was $5.90 B(Q1: Mar 2021), $6.53 B(Q2: Jun 2021), $6.71 B(Q3: Sep 2021), $6.85 B(Q4: Dec 2021) in fiscal year 2021.
2020
Amgen's annual revenue was $25.42 B in fiscal year 2024.
Amgen's quarterly revenue was $6.16 B(Q1: Mar 2020), $6.21 B(Q2: Jun 2020), $6.42 B(Q3: Sep 2020), $6.63 B(Q4: Dec 2020) in fiscal year 2020.
2019
Amgen's annual revenue was $23.36 B in fiscal year 2024.
Amgen's quarterly revenue was $5.56 B(Q1: Mar 2019), $5.87 B(Q2: Jun 2019), $5.74 B(Q3: Sep 2019), $6.20 B(Q4: Dec 2019) in fiscal year 2019.
2018
Amgen's annual revenue was $23.75 B in fiscal year 2024.
Amgen's quarterly revenue was $5.55 B(Q1: Mar 2018), $6.06 B(Q2: Jun 2018), $5.90 B(Q3: Sep 2018), $6.23 B(Q4: Dec 2018) in fiscal year 2018.
2017
Amgen's annual revenue was $22.85 B in fiscal year 2024.
Amgen's quarterly revenue was $5.46 B(Q1: Mar 2017), $5.81 B(Q2: Jun 2017), $5.77 B(Q3: Sep 2017), $5.80 B(Q4: Dec 2017) in fiscal year 2017.
2016
Amgen's annual revenue was $22.99 B in fiscal year 2024.
Amgen's quarterly revenue was $5.53 B(Q1: Mar 2016), $5.69 B(Q2: Jun 2016), $5.81 B(Q3: Sep 2016), $5.97 B(Q4: Dec 2016) in fiscal year 2016.
2015
Amgen's annual revenue was $21.66 B in fiscal year 2024.
Amgen's quarterly revenue was $5.03 B(Q1: Mar 2015), $5.37 B(Q2: Jun 2015), $5.72 B(Q3: Sep 2015), $5.54 B(Q4: Dec 2015) in fiscal year 2015.
| 2014 | 0 |
|---|---|
| 2015 | +7.97 |
| 2016 | +6.14 |
| 2017 | -0.62 |
| 2018 | +3.93 |
| 2019 | -1.62 |
| 2020 | +8.83 |
| 2021 | +2.18 |
| 2022 | +1.32 |
| 2023 | +7.09 |
| 2024 | +18.57 |
| Q1: Mar 15 | 11.32 |
|---|---|
| Q2: Jun 15 | 3.67 |
| Q3: Sep 15 | 13.75 |
| Q4: Dec 15 | 3.85 |
| Q1: Mar 16 | 9.82 |
| Q2: Jun 16 | 5.92 |
| Q3: Sep 16 | 1.54 |
| Q4: Dec 16 | 7.75 |
| Q1: Mar 17 | -1.14 |
| Q2: Jun 17 | 2.14 |
| Q3: Sep 17 | -0.65 |
| Q4: Dec 17 | -2.73 |
| Q1: Mar 18 | 1.65 |
| Q2: Jun 18 | 4.29 |
| Q3: Sep 18 | 2.27 |
| Q4: Dec 18 | 7.38 |
| Q1: Mar 19 | 0.05 |
| Q2: Jun 19 | -3.10 |
| Q3: Sep 19 | -2.83 |
| Q4: Dec 19 | -0.53 |
| Q1: Mar 20 | 10.87 |
| Q2: Jun 20 | 5.71 |
| Q3: Sep 20 | 11.96 |
| Q4: Dec 20 | 7.05 |
| Q1: Mar 21 | -4.22 |
| Q2: Jun 21 | 5.16 |
| Q3: Sep 21 | 4.41 |
| Q4: Dec 21 | 3.20 |
| Q1: Mar 22 | 5.71 |
| Q2: Jun 22 | 1.04 |
| Q3: Sep 22 | -0.81 |
| Q4: Dec 22 | -0.10 |
| Q1: Mar 23 | -2.13 |
| Q2: Jun 23 | 5.94 |
| Q3: Sep 23 | 3.77 |
| Q4: Dec 23 | 19.84 |
| Q1: Mar 24 | 21.98 |
| Q2: Jun 24 | 20.07 |
| Q3: Sep 24 | 23.18 |
| Q4: Dec 24 | 10.86 |
2024
Amgen’s annual revenue increased +18.57% during fiscal year 2024 compared to 2023. It represents a growth of $5.23 B from $28.19 B (in 2023) to $33.42 B (in 2024).
2023
Amgen’s annual revenue increased +7.09% during fiscal year 2023 compared to 2022. It represents a growth of $1.87 B from $26.32 B (in 2022) to $28.19 B (in 2023).
2022
Amgen’s annual revenue increased +1.32% during fiscal year 2022 compared to 2021. It represents a growth of $344.00 M from $25.98 B (in 2021) to $26.32 B (in 2022).
2021
Amgen’s annual revenue increased +2.18% during fiscal year 2021 compared to 2020. It represents a growth of $555.00 M from $25.42 B (in 2020) to $25.98 B (in 2021).
2020
Amgen’s annual revenue increased +8.83% during fiscal year 2020 compared to 2019. It represents a growth of $2.06 B from $23.36 B (in 2019) to $25.42 B (in 2020).
2019
Amgen’s annual revenue decreased -1.62% during fiscal year 2019 compared to 2018. It represents a decline of -$385.00 M from $23.75 B (in 2018) to $23.36 B (in 2019).
2018
Amgen’s annual revenue increased +3.93% during fiscal year 2018 compared to 2017. It represents a growth of $898.00 M from $22.85 B (in 2017) to $23.75 B (in 2018).
2017
Amgen’s annual revenue decreased -0.62% during fiscal year 2017 compared to 2016. It represents a decline of -$142.00 M from $22.99 B (in 2016) to $22.85 B (in 2017).
2016
Amgen’s annual revenue increased +6.14% during fiscal year 2016 compared to 2015. It represents a growth of $1.33 B from $21.66 B (in 2015) to $22.99 B (in 2016).
2015
Amgen’s annual revenue increased +7.97% during fiscal year 2015 compared to 2014. It represents a growth of $1.60 B from $20.06 B (in 2014) to $21.66 B (in 2015).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2024 | $33.42 B | +18.57% |
| 2023 | $28.19 B | +7.09% |
| 2022 | $26.32 B | +1.32% |
| 2021 | $25.98 B | +2.18% |
| 2020 | $25.42 B | +8.83% |
| 2019 | $23.36 B | -1.62% |
| 2018 | $23.75 B | +3.93% |
| 2017 | $22.85 B | -0.62% |
| 2016 | $22.99 B | +6.14% |
| 2015 | $21.66 B | +7.97% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q4: Dec 24 | $9.09 B | 10.86% |
| Q3: Sep 24 | $8.50 B | 23.18% |
| Q2: Jun 24 | $8.39 B | 20.07% |
| Q1: Mar 24 | $7.45 B | 21.98% |
| Q4: Dec 23 | $8.20 B | 19.84% |
| Q3: Sep 23 | $6.90 B | 3.77% |
| Q2: Jun 23 | $6.99 B | 5.94% |
| Q1: Mar 23 | $6.11 B | -2.13% |
| Q4: Dec 22 | $6.84 B | -0.10% |
| Q3: Sep 22 | $6.65 B | -0.81% |
| Q2: Jun 22 | $6.59 B | 1.04% |
| Q1: Mar 22 | $6.24 B | 5.71% |
| Q4: Dec 21 | $6.85 B | 3.20% |
| Q3: Sep 21 | $6.71 B | 4.41% |
| Q2: Jun 21 | $6.53 B | 5.16% |
| Q1: Mar 21 | $5.90 B | -4.22% |
| Q4: Dec 20 | $6.63 B | 7.05% |
| Q3: Sep 20 | $6.42 B | 11.96% |
| Q2: Jun 20 | $6.21 B | 5.71% |
| Q1: Mar 20 | $6.16 B | 10.87% |
| Q4: Dec 19 | $6.20 B | -0.53% |
| Q3: Sep 19 | $5.74 B | -2.83% |
| Q2: Jun 19 | $5.87 B | -3.10% |
| Q1: Mar 19 | $5.56 B | 0.05% |
| Q4: Dec 18 | $6.23 B | 7.38% |
| Q3: Sep 18 | $5.90 B | 2.27% |
| Q2: Jun 18 | $6.06 B | 4.29% |
| Q1: Mar 18 | $5.55 B | 1.65% |
| Q4: Dec 17 | $5.80 B | -2.73% |
| Q3: Sep 17 | $5.77 B | -0.65% |
| Q2: Jun 17 | $5.81 B | 2.14% |
| Q1: Mar 17 | $5.46 B | -1.14% |
| Q4: Dec 16 | $5.97 B | 7.75% |
| Q3: Sep 16 | $5.81 B | 1.54% |
| Q2: Jun 16 | $5.69 B | 5.92% |
| Q1: Mar 16 | $5.53 B | 9.82% |
| Q4: Dec 15 | $5.54 B | 3.85% |
| Q3: Sep 15 | $5.72 B | 13.75% |
| Q2: Jun 15 | $5.37 B | 3.67% |
| Q1: Mar 15 | $5.03 B | 11.32% |
